Nexome Cap. Mkt. (508905)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Price-to-book of 0.15 implies the market values the company at only 15% of its ₹339.50 per-share book value, offering a potential margin of safety if assets are genuine.
• Market cap of just ₹32 crore against a stated book value of ₹339.50 per share suggests the balance sheet could be worth far more than the market is paying.
• Low capital base as a financial-services entity may allow even small asset realisations to move the stock meaningfully.
• With no debt-to-equity data indicating leverage, the downside is not compounded by heavy borrowing, though data is limited.

Concerns

• Sales growth of -84.82% and profit growth of -500% show a sharply deteriorating business, with latest quarterly sales of only ₹1 crore and a net loss of ₹1 crore.
• ROE of 1.21% and ROCE of 1.24% indicate the company earns negligible returns on its large stated book value.
• Piotroski F-Score of 3/9 points to weak financial health and several red flags in operations, profitability, and efficiency.
• Zero dividend yield, undisclosed promoter holding, and a price trading below the 52-week low of ₹68.60 raise serious governance and transparency concerns.

AI Analysis

As a value investor, I'm drawn to the balance sheet before the income statement. Nexome Cap. Mkt. presents a peculiar set of numbers. The market capitalisation is only ₹32 crore, while book value stands at ₹339.50 per share. That gives a price-to-book ratio of 0.15, meaning the market is pricing this at an 85% discount to reported book value. That is either a deep value bargain—or a warning that the assets' real worth is far lower than stated. But I cannot overlook the fundamentals. Return on equity is just 1.21%, and return on capital employed is similarly 1.24%. This is not a great compounding machine; it is barely earning anything on its stated assets. Sales have collapsed by 84.82%, and profit growth is negative 500%, with the latest quarter showing ₹1 crore of sales and a ₹1 crore net loss. A business that cannot generate meaningful earnings at a P/E of 35.36 deserves suspicion. In Graham's terms, price is what you pay, value is what you get; but if the earnings engine is broken, the asset value may not translate into realised value for minority shareholders. The Piotroski score of 3 out of 9 reinforces my caution. It tells me financial health is weak and there are measurable red flags. No dividend, no promoter holding disclosure, and a price below the 52-week range of ₹68.60–₹167.95 further reduce my comfort. I would call this an asset play, not a business I can confidently own. I need proof that the book value is real and that management can monetise it. Until then, I remain on the sidelines, watching from a safe distance.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer